Professor Ilan RON is one of the most renowned and important specialists in Israeli oncology, a world-renowned expert in the treatment of malignant tumors. Chief of the Medical Center’s Oncology Department and head of the university’s cancer drug development laboratory. Professor of Medicine. Total clinical experience – more than 30 years.
Ilan Ron specializes in clinical oncology, radiation and biological therapies. It treats melanomas, gastrointestinal tumors, breast cancer and other oncological diseases with high efficiency. The physician’s special professional interest is in the therapy of metastatic cancer. To do this, Ilan Ron utilizes all innovative technological possibilities.
He is also active in the study and application of immune therapy in the treatment of certain cancers, particularly melanoma. One of the drugs that Ilan Ron successfully uses in his practice is Keytruda (Rembrolizumab). This is the newest drug from the class of immune therapy, which has now shown to be highly effective, is prescribed for any cancer in case of ineffectiveness of standard treatment protocols.
In addition to his busy clinical practice, Prof. Ilan Ron has a strong academic and research focus on oncology with leading experts in the field. He runs a research laboratory that develops anti-cancer pharmaceuticals. He has published more than 100 scientific articles in the world’s leading medical publications in the field of oncology. He is a well-known and sought-after lecturer, lecturing in clinical oncology at Tel Aviv University.